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In Europe, 17% of all those seeking treatment for drug problems 
(about 70,000 cases) do so as a result of cocaine use, while for 
those seeking treatment for the fi rst time in their life the fi gure for 
cocaine users is 24%. Moreover, there are differences in treatment 
demand between countries, Spain reporting the highest proportions 
of primary cocaine clients in Europe (46%) (European Monitoring 
Centre for Drugs and Drug Addiction, 2010). As regards treatment, 
behavioral interventions that include contingency management 
(CM) have obtained positive results in treatment for addiction 
to cocaine and other drugs (Dutra et al., 2008; Knapp, Soares, 
Farrell, & Silva da Lima, 2008; Lussier, Heil, Mongeon, Badger, 
& Higgins, 2006; Prendergast, Podus, Finney, Greenwell, & Roll, 
2006).
The Community Reinforcement Approach (CRA) plus vouchers 
(Budney & Higgins, 1998) is a treatment modality developed for the 
treatment of cocaine addiction in outpatient settings that involves a CM 
procedure in which patients earn vouchers exchangeable for goods or 
services contingent upon cocaine-free urinalysis. Results from a series 
of randomized clinical trials carried out in the USA (Higgins, Alessi, 
& Dantona, 2002; Higgins et al., 1994; Higgins et al., 1995; Higgins 
et al., 1993; Higgins et al., 2007; Higgins et al., 2003; Higgins, Wong, 
Badger, Ogden, & Dantona, 2000) and recently in Spain (García-
Fernández et al., in press; García-Rodríguez et al., 2009; Secades-
Villa et al., in press; Secades-Villa, García-Rodríguez, Higgins, 
Fernández-Hermida, & Carballo, 2008) support the effi cacy of this 
program in the treatment of cocaine addiction. But while the CRA 
plus vouchers program has demonstrated its effi cacy in comparison 
to standard programs, not all patients respond to treatment, raising the 
question about how best to implement CM interventions.
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Voucher-based contingency management (CM) research has demonstrated effi cacy for treating cocaine 
addiction, but few studies have examined associations between individual baseline characteristics and 
response to CM treatments. The aim of this study, involving 50 cocaine outpatients receiving CM for 
cocaine addiction, was to assess the impact of baseline characteristics on abstinence outcomes after 
six months of treatment. Patients who were abstinent after six months of treatment accounted for 58% 
of the sample. Patients with higher scores on the Alcohol area of the EuropASI and patients that were 
non-abstinent during the fi rst month of treatment were less likely to achieve abstinence. These outcome 
predictors have implications both for treatment research and for clinical practice. Patients who do not 
respond early to treatment may need a more intensive intervention, and concomitant problematic alcohol 
use should be detected and treated. The remaining baseline variables examined were not statistically 
signifi cant predictors of abstinence. This fi nding is important for the generalizability of CM across the 
range of individual characteristics of treatment-seeking cocaine abusers.
Características individuales y efi cacia del Manejo de Contingencias en el tratamiento de la adicción a 
la cocaína. Los programas de manejo de contingencias (MC) basados en incentivos han demostrado su 
efi cacia en el tratamiento de la adicción a la cocaína, pero pocos estudios han evaluado la relación entre 
el perfi l de adictos a la cocaína y la efi cacia de los procedimientos de MC. El objetivo de este estudio, en 
el que participaron 50 adictos a la cocaína en tratamiento en un programa de MC, consistió en evaluar 
el impacto de las características individuales de los pacientes sobre la abstinencia. El 58% de los 
participantes se encontraban abstinentes a los seis meses de tratamiento. Los pacientes con puntuaciones 
más altas en el área de Alcohol del EuropASI, y aquellos que consumieron cocaína durante el primer mes 
de tratamiento, tenían menos probabilidad de logar la abstinencia a los seis meses. Las implicaciones 
clínicas de estos resultados apuntan la necesidad de reforzar las intervenciones cuando los pacientes no 
respondan inicialmente a tratamiento, y detectar e intervenir sobre el consumo problemático de alcohol. 
El resto de variables examinadas no predecían de forma signifi cativa la abstinencia. Este hallazgo es 
importante para generalizar el uso de programas de MC entre distintos perfi les de adictos a la cocaína 
que demandan tratamiento.
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Progress has been made in identifying predictors of successful 
cocaine treatment outcomes, but although a few variables 
have been found to be associated with poor treatment outcome, 
including cocaine-use variables, baseline urine cocaine results, 
cocaine withdrawal symptoms, comorbid depression, alcohol use 
and impulsivity, there are mixed fi ndings among different trials, 
making it diffi cult to identify robust predictors (Poling, Kosten, & 
Sofuoglu, 2007).
Moreover, while CM outcome research continues to grow, 
relatively few studies have examined associations between 
individual-level characteristics and response to CM treatments. In 
recent studies it was found that income does not affect CM effi cacy 
(Rash, Olmstead, & Petry, 2009), and that the effectiveness 
of abstinence-based incentives interacts with intake stimulant 
urinalysis results (Stitzer et al., 2007). Other recent research has 
explored associations between individual characteristics such as 
PTSD symptoms and outcomes in CM, fi nding that patients with 
PTSD entering CM for cocaine dependence are not at increased risk 
for substance use (Burns, Lehman, Milby, Wallace, & Schumacher, 
2010). In the same direction, prize-based contingency management 
was found to be effi cacious in cocaine-abusing patients with and 
without recent gambling participation (Petry & Alessi, 2010). 
On the other hand, only a few studies have examined predictive 
factors of success in CM cocaine treatments in settings other than 
that of the USA, and they have focused on prediction of retention 
rather than on cocaine abstinence (García-Rodríguez et al., 2007; 
Santonja-Gómez et al., 2010). 
Sound predictors of success in CM cocaine treatments are 
necessary for understanding how individual differences affect 
treatment outcomes and increase success rates. This would make it 
possible to identify those patients in whom treatment is ineffective, 
direct CM approaches toward those patients most likely to benefi t, 
and analyze the generalizability of CM across patients.
This study focuses on the identifi cation of potential predictors of 
successful abstinence outcomes in an outpatient treatment program 
involving CM procedures for cocaine addicts in Spain. Specifi cally, 
we assessed whether individual baseline characteristics (including 
sociodemographic characteristics, addiction severity, cocaine 
use during fi rst 4 weeks of treatment, psychosocial functioning 
and psychopathological variables) affect abstinence outcomes 
at six months of treatment and examined the impact of patients’ 
characteristics on the effectiveness of CM.
Method
Participants
Inclusion criteria were being at least 20 years old, meeting 
Diagnostic and Statistical Manual of Mental Disorders (Revised 
Fourth Edition) criteria for active cocaine dependence (American 
Psychiatric Association, 2000), and not presenting serious 
psychopathological disorders (such as psychosis or dementia) or 
active opioid dependence.
The sample results from a combined dataset from two 
randomized clinical trials designed with parallel procedural 
elements. The two studies shared the same population (cocaine-
dependent adults seeking outpatient treatment), recruitment 
methods and data-collection schedules, and both involved CRA 
plus vouchers outpatient treatment and measures. There were no 
differences in participants’ baseline characteristics across studies. 
The fi nal sample was made up of 50 patients (82% males), with 
a mean age of 31.4 years (SD= 6.0). Average years of regular 
cocaine use was 6.93 (SD= 4.72), and 96% of the sample used the 
intranasal route of cocaine administration. Seventy-four percent of 
the sample presented problematic use of alcohol, and 46% used 
cannabis. 
Instruments 
Patients were informed about the treatment intervention 
characteristics, the urinalysis monitoring and the assessments 
schedule before being asked to give informed consent. Assessments 
were carried out at intake, participants being asked to complete 
several instruments, including the Michigan Alcoholism Screening 
Test (MAST) (Selzer, 1971), the Beck Depression Inventory (BDI) 
(Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), the Cocaine-
dependence criteria of the DSM-IV-TR (American Psychiatric 
Association, 2000), the European version of the Addiction 
Severity Index, the EuropASI (Díaz Mesa et al., 2010; Kokkevi 
& Hartgers, 1995), and the Symptom Checklist-90-Revised (SCL-
90-R) (Derogatis, 1983). 
Urine specimens were screened on-site for the detection of 
cocaine use by means of the Quickscreen Test by the Perfelena 
Company (Madrid). The Quickscreen test is a chromatographic 
immunoassay that rapidly detects patients’ cocaine use. The 
reagents in this test detect benzoylecgonine (a cocaine metabolite) 
at a concentration of 300ng/mL.
Variables
The primary treatment outcome variable for analysis was 
cocaine abstinence at six months of treatment (point-prevalence 
abstinence). Abstinence at the 6-month assessment was validated 
by means of concordance between urine toxicology, patient self-
reports and family reports (agreement was needed between all 
three measures). Patients lost during the 6-month period were 
considered non-abstinent. Missing urine samples were considered 
positive, which is a recommended method for dealing with missing 
data in substance abuse treatment research.
The predictor variables used in the analysis were: 
sociodemographic (gender, age, years of education, marital 
status, employment and served time in prison); addiction severity 
(administration route, years of cocaine use, other regular drug 
abuse in lifetime and MAST scores); psychological functioning 
(EuropASI composite scores); psychopathological profi le (SCL-
90-R and BDI scores); and early treatment cocaine use, defi ned 
as positive urine analysis at week 4 of treatment (1-month point-
prevalence).
CRA plus vouchers treatment
The CRA was implemented according to the manual published 
by Budney and Higgins (Budney & Higgins, 1998) and was 
made up of fi ve components: drug avoidance skills; lifestyle 
change; relationship counseling; other substance abuse; and other 
psychiatric problems. 
Urine specimens were screened three times a week from weeks 
1 to 12, and twice a week from weeks 13 to 24 in accordance with 
the original format of the CRA plus vouchers program. Patients 
were informed of their urinalysis results immediately after 
GLORIA GARCÍA-FERNÁNDEZ, ROBERTO SECADES-VILA, OLAYA GARCÍA-RODRÍGUEZ, HELI ÁLVAREZ-LÓPEZ, EMILIO SÁNCHEZ-HERVÁS, JOSÉ RAMÓN FERNÁNDEZ-HERMIDA AND SERGIO FERNÁNDEZ-ARTAMENDI116
submitting their specimens and received incentives in exchange 
for maintaining abstinence.
The main details of the voucher program implementation have 
been described previously (Budney & Higgins, 1998; Secades-Villa 
et al., 2008). Points were exchangeable for vouchers that allowed 
participants to acquire a variety of goods or services compatible 
with a drug-free lifestyle. All these goods and services were 
fi nanced through collaborating institutions from the community 
and companies (García-Rodríguez, Secades-Villa, Higgins, 
Fernández-Hermida, & Carballo, 2008). All the incentives selected 
by the participants had to be approved by the therapist and deemed 
to be in accordance with individual treatment goals.
Data analysis
Various descriptive and frequency analyses in relation to 
participants’ characteristics were carried out. Comparisons between 
the groups from the two clinical trials in baseline characteristics 
were calculated using either 2-sample t tests for continuous 
variables or χ2 tests for categorical variables. 
The number of potential predictor variables was reduced by 
testing for statistical signifi cant differences between baseline 
characteristics of abstinent and nonabstinent participants at six 
months of treatment follow-up using χ2 tests for categorical 
variables and independent t tests for continuous variables.
A logistic regression analysis was conducted to examine the 
usefulness of baseline participants’ characteristics (independent 
variables) in predicting likelihood of cocaine abstinence at six 
months of treatment (dependent variable).
Confi dence level used was 95%. The statistical software 
package SPSS-15 was used for the analysis.
Results
Participant characteristics and abstinence rates
Patients that were abstinent at six months of treatment 
accounted for 58% of the sample (n= 29). Abstinent and non-
abstinent participants were compared in all studied variables in 
order to assess variables related to abstinence. Comparison data 
are shown in Table 1. 
Results showed that there were only statistically signifi cant 
differences between the two groups on Alcohol EuropASI composite 
scores and on cocaine use during week 4 of treatment (1-month 
point prevalence). Patients that were non-abstinent after six months 
of treatment scored signifi cantly higher on the Alcohol area of the 
EuropASI compared to abstinent participants [t (48)= -2.51, p= .01], 
and 96.6% of participants that provided a negative cocaine toxicology 
sample during week 4 of treatment (28 of 29) were abstinent after 
six months of treatment [χ2 (1, n= 50)= 6.02, p= .01].
For all the other variables examined there were no signifi cant 
differences between the abstinence groups.
Factors associated with abstinence
 
As there was no statistically signifi cant relationship between 
6-month cocaine abstinence and most participants’ baseline 
variables, only the Alcohol EuropASI scores and cocaine urinalysis 
results after one month of treatment were considered as predictive 
factors for cocaine abstinence.
We conducted a logistic regression analysis to examine the 
usefulness of week-4 cocaine urinalysis results and Alcohol 
Composite scores of the EuropASI for predicting the likelihood 
of cocaine abstinence at six months of treatment. The full model 
containing both predictors was statistically signifi cant [χ2 (2, n= 50) 
= 13.67, p= .00], indicating that the model was able to distinguish 
between participants who were abstinent and non-abstinent after 
six months of CRA + vouchers treatment. The model as a whole 
explained between 23.9% (Cox and Snell R square) and 32.2% 
(Nagelkerke R square) of the variance in cocaine abstinence status, 
and correctly classifi ed 76% of cases. As shown in Table 2, both 
independent variables made statistically signifi cant contributions to 
Table 1
Baseline characteristics of abstinent and non-abstinent participants
Variables
Participants (N= 50) 
Abstinent
(N= 29)
Nonabstinent
(N= 21)
p
Demographics
Gender (% male)
Age, yearsa
Education, yearsa
Marital status (% never married)
Employed
Served time in prison (%) 
79.3
30.5 ± 5.4
10.1 ± 2.0
51.7
51.7
13.8
85.7
32.6 ± 6.7
10.4 ± 3.0
47.6
66.7
15.0
.83
.22
.66
.56
.44
1
Cocaine use
Intranasal route (%)
Years of regular cocaine usea
Other drug abuse in lifetimeb (%)
Alcohol
Cannabis 
Amphetamines 
MAST scorea
100
6.5 ± 4.5
69.0
47.6
17.2
5.3 ± 4.8
90.5
7.5 ± 5.0 
81.0
44.8
10.0
7.2 ± 4.1
.33
.45
.53
1
.76
.15
ASI Composite Scoresa
Medical
Employment
Alcohol
Drugs
Legal 
Family/social
Psychiatric
SCL-90-Ra
Somatization
Obsessive-Compulsive
Interpersonal sensitivity
Depression
Anxiety
Hostility
Phobic anxiety
Paranoid ideation
Psychoticism
Global severity 
Positive symptom distress 
Positive symptom total
BDI scorea
Week-4 cocaine urinalysisc
Positive (%)
0.22 ± 0.27
0.38 ± 0.32
0.24 ± 0.21
0.20 ± 0.10
0.12 ± 0.21
0.36 ± 0.19 
0.22 ± 0.23
60.5 ± 38.3
74.4 ± 32.4 
63.2 ± 37.3
69.6 ± 34.0
63.5 ± 37.0 
53.6 ± 34.5
60.5 ± 39.9
56.2 ± 41.4
68.7 ± 31.8
68.7 ± 35.7 
69.0 ± 35.0
65.3 ± 28.2
13.3 ± 6.9
3.4
0.22 ± 0.27 
0.31± 0.30
0.40 ± 0.22
0.19 ± 0.08
0.14 ± 0.21
0.32 ± 0.18
0.35 ± 0.23
58.1 ± 37.6 
76.4 ± 28.8
68.5 ± 31.6
69.9 ± 32.7
66.4 ± 35.0
65.1 ± 31.9
62.8 ± 37.3
68.6 ± 31.8
72.8 ± 29.2
74.4 ± 31.2
77.1 ± 27.7
69.0 ± 31.8
15.2 ± 8.3
33.3
.97
.44
.01
.69
.70
.50
.06
.82
.82
.59
.97
.78
.23
.84
.23
.64
.56
.36
.66
.38
.01
a  Means  SD
b  Three or more times per week, binges, or problematic irregular use in which normal 
activities are compromised
c  1-month point prevalence
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the model. The strongest predictor of achieving cocaine abstinence 
was 1-month point prevalence, with an odds ratio of 14.9. This 
indicated that participants who were abstinent after one month of 
treatment were over 14 times more likely to be abstinent after six 
months of treatment than those who used cocaine at week 4 of 
treatment. The odds ratio of .03 for Alcohol EuropASI composite 
scores was less than 1, indicating that for every additional higher 
score on this scale, participants were 0.03 times less likely to report 
achieving cocaine abstinence after six months of treatment.
Discussion
The main objective of this study was to analyze abstinence 
outcomes in cocaine outpatients receiving a CM intervention, and 
to determine which variables affect patients’ abstinence. The global 
abstinence rate after six months of treatment was 58% of the sample, 
which is consistent with CRA plus vouchers treatment outcomes in 
previous studies (Higgins et al., 1995; Higgins et al., 1993).
The predictive analysis showed that the result of week-4 
cocaine urinalysis testing was predictive of abstinence outcomes at 
the six-month follow-up. This fi nding is consistent with results of 
previous clinical trials highlighting how success in attaining early 
abstinence in treatment moderates the outcome of CM interventions 
(Stitzer, Petry, & Peirce, 2010; Stitzer et al., 2007; Weinstock, 
Rash, & Petry, 2010). In the same direction, the achievement of 
longer periods of abstinence during treatment has also been found 
to be associated with posttreatment abstinence among cocaine-
dependent outpatients (Higgins, Badger, & Budney, 2000).
Failure to attain abstinence at the beginning of CM treatment 
appears to be an indicator of poorer outcomes, indicating the 
need to identify timeframes over which CM is effective. In one 
of the studies mentioned above (Weinstock et al., 2010), patients 
who responded to CM attained abstinence during the fi rst 
weeks of treatment, and few participants initiated any period of 
abstinence after week 4. Therefore, the fi rst 4 weeks of treatment 
were considered to be an appropriate timeframe for monitoring 
initial patient response to CM interventions, and for considering 
alternative treatment options for those who not respond to 
treatment. Possible alternatives suggested included increasing the 
value of vouchers; combining CM with behavioral contingencies 
for counseling attendance; abstinence initiation bonuses; increasing 
number of visits; or implementing other treatment alternatives over 
and above CM interventions (e.g., intensive outpatient treatment, 
pharmacological treatment or inpatient treatment) (Tzilos, Rhodes, 
Ledgerwood, & Greenwald, 2009; Weinstock et al., 2010).
Furthermore, results showed that problems associated with 
concomitant alcohol use also predicted treatment abstinence 
outcomes. Alcohol abuse has been associated with more severe 
cocaine dependence and use of other drugs in cocaine-dependent 
outpatients, though there are contradictory fi ndings about whether 
concomitant alcohol use predicts negative treatment outcome 
(Poling et al., 2007). Our fi nding is consistent with previous 
studies indicating that those who use cocaine and alcohol had 
poorer outcomes in standard treatments for cocaine addiction than 
those who use only cocaine (Fernández-Montalvo & López-Goñi, 
2010; McKay, Alterman, Rutherford, Cacciola, & McLellan, 1999; 
Schmitz, Bordnick, Kearney, Fuller, & Breckenridge, 1997).
The remaining participant characteristics examined 
(sociodemographic variables, drug use variables, 
psychopathological profi le and psychological functioning) were 
not statistically signifi cant different between abstainers and non-
abstainers, and did not have an impact on treatment outcomes. 
Therefore, these variables may not negatively affect CM treatment 
outcomes, and the implementation of CRA plus vouchers program 
for cocaine addiction may not be limited to a certain patient 
profi le. In this regard, recent studies have demonstrated that some 
individual differences, including those related to socioeconomic 
variables, recent gambling or psychopathological disorders such as 
antisocial personality disorder, do not affect CM effi cacy (Messina, 
Farabee, & Rawson, 2003; Petry & Alessi, 2010; Rash et al., 2009). 
Moreover, in another recent study of cocaine group treatment 
outcome in methadone maintenance patients (Tzilos et al., 2009), it 
was found that successful patients were not qualitatively different 
from treatment-resistant patients, and differences were found only 
in baseline cocaine-free urinalysis and higher methadone dose. 
Thus, it was argued that early abstainers could be simply more 
sensitive to CM intervention, and increasing therapy doses may 
overcome this group difference.
We conclude that cocaine-positive urinalysis at week 4 of 
treatment and concomitant problematic alcohol use at baseline are 
associated with poorer treatment outcomes in cocaine-dependent 
patients receiving CRA plus vouchers program. These outcome 
predictors may have implications both for treatment research 
and for clinical practice. Patients who do not respond early to 
CM treatment may need a more intensive intervention, and 
complementary intervention strategies should be implemented to 
detect and treat concomitant problematic alcohol use in order to 
achieve higher abstinence rates.
Finally, the limitations of the present study include the fact that 
the sample is not very large, affecting the validity of the data; the need 
for more potential predictor variables to be examined, especially 
those most specifi cally related to the treatment; and the fact that we 
cannot attribute outcomes to the CM component of treatment and/
or the content of CRA intervention. On the other hand, the fact that 
participants came from a multi-study dataset in different community-
based clinics increases the generalizability of the fi ndings. More 
research exploring cocaine treatment predictors and the action 
mechanisms of treatment programs should be carried out, with a 
view not only to improving treatment retention and abstinence, 
but also to allaying concerns about the effectiveness of CM among 
different substance abusers for disseminating information about and 
increasing the use of this evidence-based program.
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Table 2
Logistic Regression Analysis Predicting Likelihood of Cocaine Abstinence
Independent variable B (SE) Wald
Odds
ratio
95%
lower
CI
upper
p
ASI Alcohol CS a -3.37 (1.57) 4.58 .03 .00 .75 .03
Week-4 cocaine urinalysisb 2.70 (1.18) 5.23 14.9 1.47 151.7 .02
a EuropASI Alcohol Composite Score
 b 1-Month point prevalence
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